Stryker (FRA:SYK) Change In Receivables : €-259 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Stryker Change In Receivables?

Stryker's change in receivables for the quarter that ended in Mar. 2024 was €237 Mil. It means Stryker's Accounts Receivable declined by €237 Mil from Dec. 2023 to Mar. 2024 .

Stryker's change in receivables for the fiscal year that ended in Dec. 2023 was €-160 Mil. It means Stryker's Accounts Receivable increased by €160 Mil from Dec. 2022 to Dec. 2023 .

Stryker's Accounts Receivable for the quarter that ended in Mar. 2024 was €3,195 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Stryker's Days Sales Outstanding for the three months ended in Mar. 2024 was 60.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Stryker's liquidation value for the three months ended in Mar. 2024 was €-11,689 Mil.

Stryker Change In Receivables Historical Data

The historical data trend for Stryker's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Change In Receivables Chart

Stryker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-506.70

290.99

-333.65

-546.58

-160.48

Stryker Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															340.91	-52.61	-39.35	-404.40	237.36

Stryker Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-259 Mil.

Stryker (FRA:SYK) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Stryker's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3195.16	/	4823.56	*	91
=	60.44

2. In Ben Graham's calculation of liquidation value, Stryker's accounts receivable are only considered to be worth 75% of book value:

Stryker's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2214.44	-	18611.6	+	0.75 * 3195.16	+	0.5 * 4623.92
=	-11,689

Stryker Change In Receivables Related Terms

Thank you for viewing the detailed overview of Stryker's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (FRA:SYK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (FRA:SYK) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SYK:USA SYK:Mexico 1SYK:Italy S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.